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Neural plasticity plays a critical role in mediating short- and long-term brain responses to environmental stimuli. A major effector
of plasticity throughout many regions of the brain is stress. Activation of the locus coeruleus (LC) is a critical step in mediating the
neuroendocrine and behavioral limbs of the stress response. During stressor exposure, activation of the hypothalamic-pituitary-
adrenal axis promotes release of corticotropin-releasing factor in LC, where its signaling promotes a number of physiological
and cellular changes. While the acute effects of stress on LC physiology have been described, its long-term effects are less clear.
This review will describe how stress changes LC neuronal physiology, function, and morphology from a genetic, cellular, and
neuronal circuitry/transmission perspective. Specifically, we describe morphological changes of LC neurons in response to
stressful stimuli and signal transduction pathways underlying them. Also, we will review changes in excitatory glutamatergic
synaptic transmission in LC neurons and possible stress-induced modifications of AMPA receptors. This review will also
address stress-related behavioral adaptations and specific noradrenergic receptors responsible for them. Finally, we summarize
the results of several human studies which suggest a link between stress, altered LC function, and pathogenesis of posttraumatic
stress disorder.
1. Introduction
Stressful stimuli and events engage a number of brain circuits
that ultimately activate the hypothalamic-pituitary-adrenal
(HPA) axis. During periods of stress, the paraventricular
nucleus of the hypothalamus (PVN) releases the stress pep-
tide corticotropin-releasing factor (CRF), which stimulates
both direct central and indirect peripheral effects, activating
signal transduction pathways that enhance catabolism of
energy stores and mobilize physiological and psychological
resources of the organism to permit an appropriate behav-
ioral response to the stressor. These pathways become dys-
regulated following chronic or traumatic stress, which leads
to destabilization of homeostasis and impaired immune,
cardiovascular, and gastrointestinal functions, and promot-
ing central nervous system (CNS) changes associated with
depressive and anxiety-like behaviors that contribute to the
diagnosis of stress-associated disorders [1–10]. The ability
to mobilize CNS function to respond to stressful stimuli
and ensure survival is explained in part by changes in neuro-
plastic adaptations. Several CNS structures have been dem-
onstrated to undergo neuroplastic changes following stress
[2, 11–24] which may contribute to stress-associated anxiety
and mood disorders [12, 14, 19, 25, 26]. Chronically altered
noradrenergic transmission is a characteristic of many neu-
ropsychiatric and neurodegenerative disorders [12, 27–34],
and therefore, short- and long-term stress-induced adapta-
tions in norepinephrine- (NE-) containing cell bodies may
contribute to these conditions. For the purposes of this
review, we consider short-term effects to refer to the immedi-
ate and primary action CRF signaling during stressor
exposure and the stress response on electrophysiological
properties such as membrane depolarization and action
potential generation that result from the opening of channels
already inserted in the membrane. Long-term effects on the
other hand include persistent changes that continue long
after the stress response and CRF signaling have ceased and
resulted from intracellular signaling cascades that promote
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receptor and channel trafficking, altered gene expression, and
neurite outgrowth.
Amajor node in the stress response that promotes norad-
renergic signaling in the CNS is the brain stem nucleus locus
coeruleus (LC). The LC and other smaller noradrenergic
brainstem nuclei, such as A1/C2 region in the solitary tract,
are activated by CRF and reciprocally communicate with
the HPA axis. Activation of A1/C2 promotes a positive feed-
back loop in stress circuitry by releasing NE in the PVN
which stimulates CRF production and release by engaging
α1-adrenoreceptors (α1AR) [35, 36]. The LC is the primary
source of NE to the forebrain [37–45], where its actions affect
sleep/wake cycles, sensory signal discrimination and detec-
tion, and cognition [2, 37, 46, 47]. It is innervated by a num-
ber of stress-responsive CRF-containing brain regions which
when released, acts on CRF receptor 1 (CRFR1) receptor to
produce acute changes in LC physiology and responsiveness
to synaptically released transmitters [48–51]. Additionally,
activation of CRFR1 stimulates Gs proteins and cAMP
production [48, 52], which promotes numerous genetic and
cellular effects [28, 50, 53–57]. These observations suggest
that LC neurons may undergo many long-lasting stress-
induced adaptations (Figure 1). These changes include recep-
tor trafficking [58–60], altered expression of genes necessary
for transmitter synthesis and release [28, 54–56, 61], protein
kinases that activate transcription factors [57] and growth
factors [18], electrophysiological properties [53, 62], and
morphological changes [50, 53, 63], all of which would
directly impact LC function at both immediate and chronic
time point poststress.
While most investigations have focused on the transient
effects of stress and CRF on LC function [48, 49, 51, 64–66],
some have examined their lasting impact [28, 50, 52–54, 56,
57, 62]. This review will summarize how stress and CRF sig-
naling persistently modify morphological and physiological
features of the locus coeruleus/norepinephrine (LC/NE) sys-
tem and its associated behaviors from a genetic, cellular, and
neuronal circuitry/transmission perspective. While the
stress-induced plastic changes that occur in LC and other
brain regions during disease pathogenesis are not entirely
clear, identifying how stress can chronically alter the func-
tion of this broadly projecting brainstem nucleus across
multiple levels of regulation represents an important step
forward in clarifying the mechanisms of conditions charac-
terized by hyperactive noradrenergic transmission.
2. LC/NE Synaptic Plasticity
Changes during Stress
2.1. Adaptive Functional and Anatomical Changes of LC after
Stress. HPA axis activation is pivotal for mediating the cen-
tral stress response. Through the release of peripheral and
central neurohormones, it mobilizes various body tissues
and brain areas to orchestrate an appropriate physiological
and behavioral response. Importantly, during stressor expo-
sure, CRF is released onto the LC by the PVN and other
CRF-containing stress-responsive structures, such as the
bed nucleus of the stria terminalis, Barrington’s nucleus,
and the central nucleus of the amygdala [67–73] which
increase its tonic discharge [51, 62, 65, 66]. LC activity corre-
lates highly with an animal’s behavioral state: during quiet
rest, LC discharges slowly in a highly regular fashion. During
periods of focused attention, a phasic mode of operation
dominates such that LC responds to salient stimuli with
high-frequency bursts of action potentials that facilitate ori-
entation and sustained attention towards behaviorally rele-
vant stimuli [74]. During stress, CRF causes increased tonic
discharge which compromises the ability of LC to respond
to salient sensory stimuli with phasic bursts. This leads to
impairments in sensory signal discrimination, several aspects
of cognition, and a generally anxious state [2, 37, 74–77].
While this might seem generally maladaptive, a consequence
of short-term stress-induced LC activation is to promote
behaviors that increase the likelihood of survival in a threat-
ening situation [2, 66]. By increasing LC discharge [51, 62,
65, 66] and therefore forebrain NE release [78–82], prefrontal
cortical operations are inhibited [3, 78], promoting a behav-
ioral phenotype characterized by broad scanning attention
and vigilance [2, 66, 81, 83], which facilitates escape from a
threatening situation.
The role of LC in stress has been the subject of study
since 1970, when karyometric studies of sleep-resistant
rabbits demonstrated an increase in nuclear size during
stress [84]. Subsequently, an extensive body of literature has
shown that LC is critical for mediating stress-induced behav-
ioral and neuroendocrine responses. The electrophysiologi-
cal effects of stress and CRF on LC have been well
characterized in a number of in vivo and ex vivo studies
[48, 49, 51, 53, 62, 65, 85]. In vivo, CRF increases tonic/spon-
taneous LC discharge [65, 86, 87] through a cyclic AMP
(cAMP)/protein kinase A-dependent mechanism that depo-
larizes the membrane by decreasing potassium conductance
[48]. Additionally, CRF has been demonstrated to decrease
sensory-evoked phasic responses by LC [65, 86]. This effect
could partially be explained by recent findings from our
laboratory that show that a high concentration of bath-
applied CRF [49] and preexposure to acute stress [62] both
diminish excitatory glutamatergic synaptic transmission in
LC. We found that these electrophysiological effects persist
for at least a week poststress in adolescent rats. Moreover,
electrophysiological changes which were absent immediately
after stressor exposure develop over seven days, including
increased intrinsic excitability and a hyperpolarized thresh-
old for action potential generation [62]. These findings
suggest that LC cells in adolescent rat brain undergo long-
lasting changes following even short-term acute stressor
exposure and lead to chronically increased forebrain NE
concentration and behavioral changes.
2.2. CRF and Morphological Changes. CRF orchestrates a
series of neuroplastic changes in LC neurons and LC-
derived cell cultures [50, 52, 53, 58, 63]. Specifically, CRF
triggers morphological changes in immortalized catechol-
aminergic neurons, such as the formation of long neurites
with prominent growth cones [52]. Similarly, another study
demonstrated the ability of CRF to promote neuronal out-
growth in organotypic slice cultures of rat LC [50]. In this
study, it was found that 12 hours of CRF exposure increased
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the number of primary processes and branching pattern of
neurites. Mechanisms of dendritic growth regulation by
CRF have been proposed to occur through Rac and RhoA
GTPases (Figure 1), which regulate intracellular actin
dynamics and spine length [88]. Elsewhere in the brain, inhi-
bition of Rac1 has been shown to promote strong effects on
dendritic spines from apical and basal dendrites on pyrami-
dal neurons with relative absence of branching effects [89].
Additional unpublished observations from our labora-
tory also suggest that in animals subjected to acute intense
stressor exposure, LC cells might undergo morphological
changes. We have previously shown that fifteen minutes of
combined physical restraint and exposure to predator odor
induces a number of long-lasting changes in LC function that
are accompanied by chronically increased anxiety-like
behavior [62]. During whole-cell patch clamp electrophysio-
logical recordings, some neurons were filled with biocytin so
their morphology could be recovered. Preliminary findings
show that LC cells from stressed animals have larger and
more complex dendritic arbors than those from control rats.
Additionally, using RNA-Seq, we identified that expression
of Ntf3, the gene for neurotrophin 3, which promotes neuro-
nal survival, differentiation, and neurite outgrowth [18, 90],
was approximately twice as high in rats one week after
stressor exposure than in their control counterparts
(Figure 2). These observations, in combination with earlier
reports of stress-induced morphological alterations in LC
neurons [50, 52, 53, 75, 91–93], suggest that stress may cause
long-lasting changes in noradrenergic transmission through-
out the CNS in response to even acute stressor exposure.
Such an effect on CNS noradrenergic transmission might
be achieved through morphological plasticity because as LC
dendrites and axons proliferate, there would be more sites
of afferent input to excite LC neurons and a greater density
of release points from which NE efflux could occur upon this
enhanced excitation, respectively. Such findings could have
important implications for posttraumatic stress disorder
(PTSD), a condition in which evidence suggests that NE
transmission is impaired [12, 31, 79, 94].
It is interesting to note that rodent LC neurons are sex-
ually dimorphic with respect to their morphological charac-
teristics and response to stress/CRF exposure. Female LC
dendritic arbors have been reported to extend further into
the peri-LC region where synaptic contacts with CRF-
positive afferents are made [71, 95, 96] and are larger with
more branching points than those of males [68, 97]. This
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Figure 1: Model of signal transduction pathways induced by stress in LC neurons. (a) Pathways which mediate short-term effects of stressor
exposure. CRF interacts with CRFR1, which through Gs-coupled receptor mechanisms increases intracellular cAMP levels, reducing
potassium conductance resulting in cell depolarization. Through unknown mechanisms, CRF decreases glutamatergic synaptic
transmission through AMPARs. (b) Pathways which mediate long-term effects of stressor. Initial CRF activation of Gs-coupled CRFR1
increases PKA activity, which phosphorylates CREB to initiate expression of stress-induced genes. These could potentially include genes
regulating AMPAR and voltage-gated ion channel expression. Inactivation of RhoA by PKA phosphorylation disinhibits Rac1 to increase
neurite outgrowth via actin remodeling and microtubule stabilization.
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suggests that the female LC might be subjected to greater
afferent regulation by CRF and therefore more stress-
responsive. This sexual dimorphism might provide a struc-
tural basis for differences in emotional arousal between
sexes and the greater increased susceptibility of females
to anxiety disorders [98]. Interestingly, in mice that genet-
ically overexpress CRF, the complexity of male dendritic
morphology increases to resemble the morphology of
wild-type and CRF-overexpressing females. This further
suggests that enhanced CRF signaling produces neurite
proliferation and extension in LC [58]. Such observations
provide further evidence for stress and CRF-induced cen-
tral noradrenergic reorganization.
2.3. CRF and Modified AMPA Receptor-Dependent Synaptic
Transmission. Plasticity is highly dependent on the AMPA
receptor (AMPAR), an ionotropic glutamate receptor, per-
meable to Na+ and Ca2+ ions. It is composed of four subunits:
GluA1, GluA2, GluA3, and GluA4, which form a heterotetra-
mer. [99–103]. We have previously shown that both stressor
exposure in vivo [62] and CRF exposure ex vivo [49] alter LC
AMPAR signaling. Given that stress and CRF can alter
AMPAR-dependent transmission, this receptor might play
a critical role in stress-induced neural plasticity. Several
mechanisms could account for altered AMPAR functioning
in LC following CRF exposure. CRF signaling in LC causes
internalization of its own receptor [59, 60, 63], and thus, if
CRF and AMPARs are in close apposition to one another
on postsynaptic LC membranes, CRF receptor trafficking
might inadvertently induce AMPAR internalization as well.
This is particularly important with respect to some of the
intracellular proteins that AMPARs interact with. AMPARs
interact directly and indirectly with kinases and GTPases
that regulate actin cytoskeletal dynamics [50, 53, 99–101,
104, 105]. In particular, Rho GTPase activity is modulated
by guanine nucleotide exchange factors (GEFs), which are
known to interact with surface-expressed AMPARs and
promote synaptic plasticity [104]. Thus, if CRF causes shut-
tling of vesicular AMPARs to the cell membrane, which,
based on our prior observations, might occur during high
concentrations of CRF exposure [49], their association with
GEFs could promote structural plasticity in LC neurons
through interaction with Rho GTPases and modulation of
cytoskeletal structure. Identifying the mechanisms that link
CRF and AMPA receptor function and trafficking could be
informative of how LC cells adapt morphologically follow-
ing stress, thus providing insights to a number of disease
states in which LC plasticity is perturbed [29, 50, 53,
106, 107]. In addition to receptor trafficking and altered
gene expression, there are other posttranslational modifica-
tions that can be made to the AMPAR and its subunits
which could promote plastic changes to LC neurons.
Using data from both LC and non-LC studies of AMPAR
function and modification, we will review possible mecha-
nisms for AMPAR regulation.
There are multiple mechanisms of posttranslational reg-
ulation of AMPAR function, which include reversible phos-
phorylation, ubiquitination, and palmitoylation [108–110].
CRF stimulates cAMP synthesis and PKA activity [48, 50,
52], and therefore, stress could potentially alter AMPAR
phosphorylation states. The GluA1 subunit is phosphory-
lated at different positions at the C-terminal end. For exam-
ple, phosphorylation at Ser-845 by PKA [101] and Ser-831
by PKC and CaMKII [111, 112] increase single channel con-
ductance. Phosphorylation of Ser-818 and Thr–840 by PKC
increases the mean channel conductance [113]. Importantly,
mechanisms that increase channel conductance have been
shown to promote activity-dependent plasticity [99, 114].
PKCλ was found to phosphorylate Ser-818 on the GluA1
subunit which mediates PI3K-induced AMPAR insertion
[115]. GluR2 can also regulate synaptic plasticity through
Ser-880 phosphorylation-dependent interactions with PDZ
domain-containing proteins, which regulate receptor inter-
nalization in the hippocampus [116] and cerebellum [117].
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Figure 2: LC neurons from stressor-exposed animals show a trend for increased dendritic complexity. Representative traced neurons from
control (top) and stressor exposed (bottom) animals filled with biocytin reveal a tendency for LC cells from stressed rats to possess larger and
more complex dendritic arbors a week after stressor exposure. Additionally, neurotrophin 3, which promotes neurite outgrowth and dendritic
proliferation, is upregulated in LC one week after stressor exposure. ∗p < 0 05 versus control.
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Thus, due to the actions of CRF on cAMP production and
PKA activity, stress could potentially impact LC plasticity
through modulation of AMPAR function which we have
demonstrated in the past [49, 62].
Another modification of AMPARs is ubiquitination,
which promotes endocytosis and degradation [108, 109,
118–120] and can occur at multiple places across the sub-
units. One effect of stress on AMPAR ubiquitination is to
decrease glutamatergic synaptic transmission in the prefron-
tal cortex (PFC), which requires specific ubiquitin ligases
Nedd4-1 and Fbx2, an effect which can be blocked by a
proteasome inhibitor [121]. Identification of LC-specific
ubiquitin ligases would help to find a precise target for stress
response control and intervention. In contrast to ubiquitina-
tion, AMPAR C-terminal cysteine residue palmitoylation
protects from degradation [122] and regulates its internaliza-
tion [123]. Palmitoylation of the transmembrane domain
promotes accumulation of AMPAR in the Golgi, possibly
performing a quality control step for proper folding, while
depalmitoylation stimulates membrane insertion of AMPAR
[123–125]. Identifying any potential mechanisms linking
CRF signaling to AMPAR ubiquitination in LC or elsewhere
would be informative of means of promoting or inhibiting
stress-induced plasticity within the nucleus.
2.4. CRF and Intracellular Signal Transduction. CRF medi-
ates its action through CRFR1, which through Gs-coupled
mechanisms increases the concentration of cAMP that phos-
phorylates PKA [52]. However, there is another mechanism
caused by CRFR1 activation which acts through a MAPK
cascade, in which a Gq-coupled mechanism increases
concentration of phospholipase C (PLC), which activates
metabolites which phosphorylate PKC, which in turn
phosphorylates ERK1/2 [50, 126]. CRF has been shown to
cause an increase in LC neurite length, an effect that is abol-
ished by specific inhibition of PKA or MAPK, but not PKC
[50]. PKC appears to also trigger a RhoA-activating cascade
through downstream Rho-associated protein kinase (ROCK),
which subsequently phosphorylates the collapsin response
mediator protein 2 (CRMP-2) and causes growth cone
collapse [127] (Figure 2).
Such receptor-mediated acute cellular changes could
occur through the aforementioned mechanisms, but long-
term changes could also potentially occur through regulation
of gene expression. A study of single and repeated restraint
stress demonstrated an increase in immunoreactivity of c-
Fos, pERK, pCaMKII, and pCREB in the LC two hours
following the stressor [128]. The same study also showed that
pERK and pCREB had the same expression pattern and were
colocalized to the same neurons, suggesting that activation of
the MAPK/ERK pathways with CREB phosphorylation
promote changes in gene expression. The exact mechanism
of transcriptional changes following CRF expression in
the LC is not clear. However, another study demonstrated
increased c-Fos expression and CREB phosphorylation
after acute immobilization stress, while repeated stress
increased phosphorylation of p38, cJun N-teminal kinase
(JNK 1/2/3), and ERK1/2 [129]. CREB is a transcriptional
factor which regulates transcription of multiple downstream
genes including c-Fos, brain-derived neurotrophic factor
(BDNF), tyrosine hydroxylase (TH), and neuropeptides
[130, 131]. These observations corroborate other studies that
have shown altered expression of trophic factors and NE
synthetic enzymes [18, 28, 54–57, 61].
BDNF stimulates dendritic outgrowth and increased syn-
aptic connectivity. Mice genetically overexpressing the recep-
tor for neurotrophin 3, TrkC, show increased anxiety-like
behavior, as well as increased LC neuronal density [132], sug-
gesting that some degree of positive feedback might exist
between stress, neurotrophin 3 signaling, and LC plasticity.
This is particularly interesting in light of preliminary obser-
vations by our laboratory that show that one week after acute
stressor exposure, neurotrophin mRNA is increased, an effect
accompanied by a trend for increased LC dendritic length
and complexity (Figure 2). Others have also reported
increased neurotrophin 3 expression in LC following stress,
which can be normalized with antidepressant treatment
[18]. Interestingly, in addition to sexual dimorphism of LC
morphology and stress responsiveness, there are also sex
differences in LC intracellular signaling induced by CRF: spe-
cifically, CRFR1 is more strongly coupled to β-arrestin in
males, promoting receptor internalization and potentially
blunted responsiveness to CRF in the future. In females,
however, CRFR1 is more strongly coupled to Gs signaling
pathways, which promotes increased LC discharge and den-
dritic proliferation, potentially increasing future sensitivity
to stress by providing more space for synaptic contacts with
CRF-positive afferents [63, 133]. In this way, the male and
female LC may be differentially aligned to respond to stress
with specific neuroplastic adaptations that promote disease.
3. CNS Neural Plasticity Changes in Response to
NE Volume Transmission Changes
LC contributes to major CNS functions such as waking,
arousal, attention, sensory discrimination, and cognition.
Because stress promotes both short- and long-term func-
tional and neuroplastic changes in LC, some of these func-
tions might also be impacted by stressor exposure, either
directly or indirectly. Through modulation of intrinsic and
synaptic features of LC neurons, stress likely modifies norad-
renergic volume transmission in target brain areas such as
the amygdala, hippocampus, and PFC, where it potently
modulates neural plasticity [134–138]. Because stress acutely
and chronically alters LC discharge [53, 62, 66, 86] and NE
release [78–82], different adrenergic receptors might become
engaged during and after stressor exposure. The adrenergic
receptors vary in their affinity for NE [3, 78, 139, 140], and
different receptors promote different forms of plasticity and
learning [134, 135, 137, 141]. Low concentrations of NE
engage the high-affinity α1 receptor, particularly in the pre-
frontal cortex, which promotes working memory, sustained
attention, and other cognitive functions [3, 142, 143].
Conversely, high NE concentration which occurs in
response to stress causes engagement of the α1 and β adren-
ergic receptors. The α1 receptor promotes LTD of prefrontal
synapses [137] and inhibition of prefrontal-dependent cogni-
tive functions such as working memory and sustained
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attention [2, 83]. Indeed, enhanced α1 signaling in PFC is
associated with increased behavioral flexibility [144]. Fur-
thermore, stressor exposure has been shown to increase tonic
LC discharge and promote scanning attention and behavioral
flexibility [65, 66]. It has been proposed that such a change
would permit lower-order sensorimotor regions to guide
behavior with little modulation by prefrontal circuitry, allow-
ing disengagement from specific stimuli and goal-oriented
behaviors to instead promote rapid impulsive responses [2].
Such a stress-induced shift might be beneficial when an
animal is faced with a threatening stimulus and a quick
escape must be made. Additionally, engagement of the β
receptor promotes hippocampal plasticity and encoding
and recall of contextual fear memory [141, 145, 146]. There-
fore, persistent stress-induced changes in LC function would
elevate NE concentration in prefrontal cortex and hippo-
campus enhancing plasticity in both areas through signaling
at α1 and β receptors to synergistically promote encoding
and recall of fear memories, impaired cognition, hypervigi-
lance, and behaviors that allow an appropriate behavioral
response to be generated. Therefore, an inverted U relation-
ship between LC firing and arousal/behavioral performance
model has been proposed [2, 37, 139], with maximal cogni-
tive function corresponding to “ideal” levels of LC tonic fir-
ing [147] and hyperarousal and vigilance corresponding
with excessive levels of discharge. During stress, increased
tonic LC firing is enhanced, which leads to increased levels
of NE in LC projection fields, promoting broad scanning
attention, hyperarousal, hypervigilance, and other anxiety-
like behavioral symptoms in stressed subjects.
4. Role of Stress-Induced LC/NE
Changes in PTSD
Chronic stress-induced alterations in LC structure and func-
tion that lead to behavioral impairments might contribute to
disease pathogenesis and symptomatology. Many studies
show the involvement or potential involvement of the LC
in stress-related disease states, particularly PTSD. Both
peripheral and central measures of NE activity are increased
in PTSD patient populations, including enhanced sympa-
thetic nervous system function [148–151], and increased
functional connectivity between LC and the basolateral
amygdala during conscious processing of threatening stimuli
[152]. This enhanced connectivity is particularly important
because of the role that the basolateral amygdala and its
noradrenergic inputs in particular [153–157] play in fear
conditioning. Furthermore, PTSD patients frequently show
disturbances in sleep patterns [158–160], which may be
related to chronically elevated LC discharge due to its well-
established role in mediating arousal and a forebrain EEG
associated with waking [161]. Such an effect could potentially
be related to dysregulation of other stress-sensitive systems,
such as the HPA axis which releases CRF. LC is potently acti-
vated by CRF, and increased levels of the peptide have been
found in the cerebrospinal fluid of combat veterans afflicted
with PTSD [162, 163], providing a potential means for main-
taining LC hyperactivity even in the absence of a stressor.
More recently, an fMRI study showed that PTSD patients
showed exaggerated behavioral and autonomic responses
to loud sounds, suggesting sensitized phasic responses of
LC neurons [34]. Evidence for LC as a central mediator
of PTSD-like symptoms comes from observations that
yohimbine, an α2A receptor antagonist which disinhibits
LC neurons, produces panic attacks in up to 70% of PTSD
patients and in 89% of patients with comorbid PTSD and
panic disorder, but not in control subjects. Additionally,
plasma levels of a NE metabolite postyohimbine adminis-
tration were twice as high in PTSD patients [163]. These
findings suggest that NE release is altered presynaptically
at the level of the LC in PTSD patients, which may affect
many downstream targets [164].
In contrast to the actions of yohimbine, clonidine, a pre-
synaptic α2A receptor agonist which limits noradrenergic
transmission in the forebrain, has been shown to have
beneficial effects on hyperarousal, hypervigilance, sleep dis-
ruption, exaggerated startle responses, and nightmares in
veterans with PTSD [31]. The notion that increased NE
release promotes some behaviors associated with PTSD and
anxiety is further supported by observations that the β-recep-
tor antagonist propranolol attenuates PTSD symptoms,
possibly due to the actions that the β receptor plays in fear
memory consolidation and emotion [31, 134, 135, 165–167].
Prazosin, an α1-adrenergic antagonist, has also been shown
to be beneficial for alleviating nightmares and sleep distur-
bances in both veteran [168] and children PTSD patients
[169], as well as for improving symptoms of hyperarousal,
avoidance/numbing, and traumatic recall of past events
[170]. It is also interesting to note that an in vivo PET study
that the availability of the NE transporter in the LC is
decreased in PTSD patients [171]. This could be indicative
of elevated extracellular NE concentration and would be con-
sistent with other reports of LC hyperactivity in this popula-
tion. Thus, due to the well-documented ability of stress to
promote forebrain NE release through short-term physiolog-
ical activation and enduringmolecular and cellular changes in
the LC, stress-induced neuroplastic adaptations in the LC
likely contribute to disease pathogenesis. This could occur at
the level of the LC as a primary site of stress-induced plasticity
or in downstream targets of the LC due to the well-established
role of NE in mediating neuroplastic changes throughout the
brain: fMRI studies have also shown changes in hippocampal
volume and altered function in the amygdala, hippocampus,
mPFC, orbitofrontal cortex, anterior cingulate, and insular
cortex in PTSD patients [172], all of which may be related to
maladaptive plastic changes in the LC or the plastic changes
promoted by it [134, 135, 137, 165].
Based on these clinical reports, there is clear evidence that
LC hyperfunction is at least characteristic of, if not causal to,
PTSD symptomatology. However, some clinical observations
suggest a more complicated relationship that exists between
LC function and PTSD disease progression and treatment.
As mentioned above, there is clinical evidence for decreased
NE transporter availability in the LC of PTSD patients. This
could be explained by elevated extracellular NE concentra-
tion; another potential explanation could be LC neuronal
loss. Indeed, a postmortem neuromorphometric analysis of
veterans with probable or possible war-related PTSD showed
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a lower LC cell count compared to controls [173], suggesting
that the LC plays in the role in the pathophysiology of PTSD,
or that a lower LC cell count may predispose individuals to
PTSD. While decreased LC cell numbers would suggest
reduced forebrain NE levels, in other pathologies in which
LC cell counts are decreased such as Alzheimer’s disease,
the surviving neurons show evidence for hyperactivity [174]
and dendritic sprouting and remodeling [107]. Additionally,
recent clinical trials using 3,4-methylenedioxymethampheta-
mine (MDMA) have shown promising results in reduction or
remission of PTSD symptoms: specifically, six phase II clini-
cal trials have shown that combinedMDMA and psychother-
apy are safe and efficacious such that 52.7% of patients
receiving active drug no longer meet PTSD criteria [175].
Despite a wealth of evidence showing that enhanced norad-
renergic transmission contributes to PTSD etiology, MDMA
increases release of catecholamines, including NE. One
potential explanation for MDMA’s somewhat paradoxical
efficacy is that memory reconsolidation is enhanced via
plastic changes in the hippocampus due to elevated NE
levels [141, 145]. MDMA also facilitates fear extinction
learning [176], and thus, enhanced NE efflux following
MDMA administration might also promote plastic changes
within the amygdala [12]. Additionally, because NE is gen-
erally increased in PTSD patients, the benefits of MDMA
on symptom improvement are likely due to the drug com-
plex polypharmacological interactions and its effects on
brainwide neurotransmission. It is hypothesized that in addi-
tion to enhanced plasticity and memory reconsolidation,
heightened monoaminergic neurotransmission following
MDMA administration promotes a number of subjective
psychological effects such as increased introspection and
receptiveness for psychotherapy that lead to improved out-
comes in PTSD patients [175]. Collectively, however, many
clinical observations strongly suggest that hyperactive norad-
renergic transmission contributes to PTSD symptomology
and anxiety-like behavior.
5. Conclusions
Stressor exposure induces a series of neuroendocrine,
physiological, and behavioral adaptations that promote an
appropriate response to the stressor. Central to these diverse
functions is CRF signaling which in a number of brain
regions promotes a number of immediate [48, 49, 51,
177–184] and persistent [50, 52, 60, 121, 185–187] cellular
changes. These effects are of particular interest in LC,
where the interaction of CRF with its receptor CRFR1
activates cAMP-dependent intracellular signaling cascades,
increasing tonic discharge and promoting anxiety-like
behavior [64, 77, 188, 189]. Evidence suggests that chronic
stressor exposure is able to alter LC gene expression [18, 28,
54–57, 61], promote long-term changes in synaptic trans-
mission and excitability [53, 62] and receptor trafficking
[58–60, 185], and, importantly, induce morphological
changes and dendritic remodeling (Figure 1) [50, 52, 53,
57, 190]. These actions appear to be dependent on a number
of kinases and GTPases and their associated signaling
pathways [50, 52, 57] and potentially on AMPAR function
[191, 192] which is modulated by CRF in the short term
[49] and stressor exposure in the long term [62]. Through
its complex signaling cascades, CRFR1 activation in LC
induces a number of long-lasting cellular effects which ulti-
mately impact the function of the nucleus itself as well as
other target brain regions which are heavily innervated
by LC and modulated by noradrenergic transmission. Crit-
ically, the LC promotes plasticity in other structures
including the PFC, amygdala, and hippocampus by pro-
moting noradrenergic transmission at α1 and β receptors
[137, 141, 145, 146]. Therefore, stress and CRF can induce
neuroplastic changes in LC, which can lead to subsequent
neuroplastic changes elsewhere, ultimately promoting caus-
ing chronic anxiety-like behavior. Specifically, increased
tonic discharge in the short term will drive an animal to dis-
play such behavior [62, 64, 77]. Maintenance of increased LC
discharge in the long term [62] along with enhanced expres-
sion of genes necessary for NE synthesis and release [54–56]
will lead to chronically elevated forebrain NE levels. This
promotes network adaptations and plasticity in target
regions which facilitate fear memory encoding and drive an
animal towards a behavioral state characterized by vigilance,
impulsivity, and impaired cognition [3, 78, 83, 193]. Mean-
while, morphological plasticity and dendritic outgrowth into
the peri-LC area [50, 52, 53, 68, 194] will make LC subject to
greater afferent regulation by stress-responsive structures
such as PVN and CeA [58, 63, 194]. Through these mecha-
nisms, chronic or traumatic stress could permanently alter
forebrain noradrenergic transmission to promote long-
lasting changes in behavior, manifesting in humans as mood
and anxiety disorders such as depression and posttrau-
matic stress disorder. Thus, identifying how stress and
CRF promote synaptic and morphological plasticity in
LC to chronically elevate forebrain NE concentration
represents an important step in understanding disease
pathogenesis and symptomatology for mood, anxiety, and
other neuropsychiatric disorders.
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